Enhancement of propylene glycol distribution in the skin by high purity cis-unsaturated fatty acids with different alkyl chain lengths having different double bond position

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 4, 1999, Pages 407-411

  Taguchi, Kenji ^a   Fukushima, Shoji ^a   Yamaoka, Yumiko ^a   Takeuchi, Yoshikazu ^a   Suzuki, Masao ^b  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b NOF Corporation   (Japan)

Author keywords

Alkyl chain length; Fourier transform attenuated total reflection spectroscopy; High purity cis unsaturated fatty acid; Skin penetration enhancer

Indexed keywords

ERUCIC ACID; MYRISTOLEIC ACID; OLEIC ACID; PALMITOLEIC ACID; PROPYLENE GLYCOL; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL TISSUE; ARTICLE; CHEMICAL BOND; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG STRUCTURE; FOURIER TRANSFORMATION; HYDROPHILICITY; MALE; NONHUMAN; RAT; SKIN PENETRATION; STEADY STATE; STRATUM CORNEUM; STRUCTURE ACTIVITY RELATION;

EID: 0032894989     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.407     Document Type: Article

References (18)

1. Wertz P. W., Dowing D. T., Biological and Biochemical Consideration, Mercel Dekker, New York, 1989, pp. 1-22.
2. Bronaugh R. L., Stewarat R. F., Kondon E.-R., Taxicol. Appl. Pharmacol., 62, 481-488 (1982).
3. Tojo K., Chiang C. C., Chien Y. W., J. Pharm. Sci., 76, 123-126 (1987).
4. Okamoto H. Muta K., Hashida M., Sezaki H., Pharm. Res., 7, 64-68 (1990).
5. Aungst B. J., Rogers N. J., Shefter E., Int. J. Pharm., 33, 225-234 (1986).
6. Morimoto K, Tojima H., Haruta T., Suzuki M., Kakemi M., J. Pharm., Pharmacol., 48, 1133-1137 (1996).
7. Morimoto K., Haruta T., Tojima H., Takeuchi Y., Drug Dev. Ind. Pharm., 21, 1999-2012 (1995).
8. Barry B. W., J. Controlled Release, 6, 85-97 (1987).
9. Bhatia K. S., Gao S., Singh J., J. Controlled Release, 47, 81-89 (1997).
10. Takeuchi Y., Yasukawa H., Yamaoka Y., Kato Y., Morimoto Y., Fukumori Y., Fukuda T., Chem. Pharm. Bull., 40, 1887-1892 (1992).
11. Takeuchi Y., Yasukawa H., Yamaoka Y., Takahashi N., Tamura C., Morimoto Y., Fukushima S., Vasavada R. C., Chem. Pharm. Bull., 41, 1434-1437 (1993).
12. Takeuchi Y., Yasukawa H., Yamaoka Y., Taguchi K., Fukushima S., Shimonaka Y., Nishinaga H., Morimoto Y., Biol. Pharm. Bull., 18, 304-309 (1996).
13. Taguchi K., Takeuchi Y., Yamaoka Y., Fukushima S., Yasukawa H., Vasavada R. C., Suzuki M., Yakuzuigaku, 57, 65-730(1997).
14. Takeuchi Y., Yamaoka Y., Fukushima S., Miyawaki K., Taguchi K., Yasukawa H., Kishimoto S., Suzuki M., Biol. Pham. Bull., 21, 484-491 (1998).
15. Kaneko F., Nishi I., Kobayashi M., Rep. Progr. Polym. Phys. Jpn., 30, 135-138 (1987).
16. Bronaugh R. L., Maibach H. I., "In Vitro Percutaneous Absorption: Principle, Fundamentals and Applications," CRG Press, Ann Arbor, 1991, pp. 165-183.
17. Yoshimoto N., Nakamura T., Suzuki M., Sato K., J. Phys. Chem., 95, 3344-3390 (1995).
18. Koyama Y., Ikeda K., Chem. Phys. Lipids, 26, 149-159 (1980).